Alcon's $200M RxSight partnership aims to recapture IOL market share with adjustable presbyopic lenses. RxSight gets 30% ...

Alcon (NYSE:ALC) and RxSight (Nasdaq:RXST) announced that they entered into a non-exclusive intraocular lens (IOL) ...

Alcon and RxSight partner to develop light-adjustable presbyopia-correcting IOLs, including $60M upfront and milestone payments.

Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologies ...

The companies will combine their expertise to develop a ‘tuneable’ presbyopia-correcting intraocular lens (PCIOL) for ...

Over the last several years, the RxSight team has been developing proprietary hybrid IOL materials for next-generation light adjustable technology that can support a full suite of adjustable lenses ...

Eyecare giant Alcon has bought a majority stake in cell therapy start-up Aurion Biotech, replacing the company's chief executive, in the culmination of a months-long struggle for control. In a ...

Google is giving you a free flight – with its new flight simulator app. The tech giant has added a free-to-play flight simulator within its Google Earth map software. What's so special about the ...

An Oregon man is suing to reverse the sale of dozens of pieces of Chinese artwork belonging to his late parents. An Oregon man is suing to reverse the sale of dozens of pieces of Chinese artwork ...

ALC is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of ALC shares has decreased $1.46 since the market last closed. This is a 2.14% ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Gordon Scott has been an active investor and ...